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Epithelial-to-mesenchymal transition (EMT) is a
developmental process important for cell fate deter-
mination. Fibroblasts, a product of EMT, can be reset
into induced pluripotent stem cells (iPSCs) via exog-
enous transcription factors but the underlying mech-
anism is unclear. Here we show that the generation of
iPSCs from mouse fibroblasts requires a mesen-
chymal-to-epithelial transition (MET) orchestrated
by suppressing pro-EMT signals from the culture
medium and activating an epithelial program inside
the cells. At the transcriptional level, Sox2/Oct4
suppress the EMT mediator Snail, c-Myc downregu-
lates TGF-b1 and TGF-b receptor 2, and Klf4 induces
epithelial genes including E-cadherin. Blocking MET
impairs the reprogramming of fibroblasts whereas
preventing EMT in epithelial cells culturedwith serum
can produce iPSCswithout Klf4 and c-Myc. Our work
not only establishes MET as a key cellular mecha-
nism toward induced pluripotency, but also demon-
strates iPSC generation as a cooperative process
between the defined factors and the extracellular
milieu.
INTRODUCTION
The direct reprogramming of somatic cells to an embryonic stem
cell (ESC)-like state by defined factors is an approach commonly
known as iPS (Takahashi and Yamanaka, 2006). This technology
is devoid of ethical concerns and can produce pluripotent stem
cells from an individual that are compatible with his/her own
immune system. Compared to somatic cell nuclear transfer
(SCNT) (Wilmut et al., 1997), iPS not only has solved a technical
hurdle but also offers a unique experimental system to investi-
gate key questions regarding cell fate determination and epige-
netic regulation. iPSC generation is viewed as a multiple-step
course of action mediated by transcription factors that progres-
sively induce the expression of ESC-like genes and suppress the
somatic cell genetic program (Brambrink et al., 2008). Becausethe appearance of iPSCs takes at least 12–24 days and is very
inefficient, nuclear reprogramming is considered a stochastic
process in which successive barriers must be overcome to reach
a state toward pluripotency (Hanna et al., 2009b; Yamanaka,
2009), but the nature of these barriers is poorly understood.
Remarkably, a series of compounds including TGF-b (transform-
ing growth factor b) inhibitors have been identified that accel-
erate or improve the reprogramming (Esteban et al., 2010;
Huangfu et al., 2008; Ichida et al., 2009; Maherali and Hochedlin-
ger, 2009; Mikkelsen et al., 2008), and thismay shed light into the
putative reprogramming roadblocks.
One of the first noticeable changes during the reprogramming
of fibroblasts is their transformation into tightly packed clusters
of rounded cells in a process that resembles a MET (Qin et al.,
2007; Takahashi and Yamanaka, 2006), the opposite of EMT.
During development, EMT events occur as early as gastrulation
and are frequent afterwards, for example in the delamination of
the neural crest (Thiery et al., 2009). EMT consists of coordinated
changes in cell-cell and cell-matrix interactions that lead to loss
of epithelial features and acquisition of mesenchymal character-
istics. A previous analysis has estimated that EMT changes the
expression of about 4000 genes (10% of the human genome)
(Zavadil et al., 2001), with two genes reproducibly changed in
all forms of EMT: E-cadherin (downregulated) and Snail (upregu-
lated). Snail is a basic helix-loop-helix transcription factor that
binds to specific cognate sequences termed E-boxes and
represses the transcription of E-cadherin and other key epithelial
regulators (Batlle et al., 2000; Cano et al., 2000; Nieto, 2002).
E-cadherin is a transmembrane constituent of intercellular adhe-
rens junctions responsible for maintaining epithelial cohesion
(Cavallaro and Christofori, 2004) and has also been linked to
the control of ESC pluripotency (Chou et al., 2008; Soncin
et al., 2009). Here we demonstrate that the exogenous reprog-
ramming factors activate an epithelial program and shut down
key mesenchymal genes to overcome the EMT epigenetic
barrier of fibroblasts and allow their successful reprogramming
into pluripotent stem cells.
RESULTS
The Reprogramming of Fibroblasts Starts with a MET
Morphological differences between elongated fibroblasts and
mouse ESCs are profound (Figure 1A). During reprogramming,Cell Stem Cell 7, 51–63, July 2, 2010 ª2010 Elsevier Inc. 51
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Figure 1. MET Is an Early Event during the Reprogramming of Mouse Fibroblasts
(A) Phase-contrast photographs of nontransduced MEFs and an iPSC line generated from the same MEFs.
(B) Phase-contrast photographs of MEFs transduced with empty vector, and SKOM or SKO combinations at days 5 and 8.
(C) Immunofluorescence microscopy for the indicated markers in a similar experiment as in (B); the nuclei are stained in blue with DAPI. Vertical computer recon-
structions are shown below each item. A representative experiment (this applies hereafter unless otherwise indicated) is shown. E-cad stands for E-cadherin (also
hereafter); scale bars indicate 50 mm (also hereafter).
(D) Western blotting for the indicated proteins of lysates corresponding to a similar experiment; actin is the loading control.
(E) qPCR for the indicated genes of three independent SKOM time-course experiments. Samples were measured in triplicate and the mean values + standard
deviation (SD) are shown (this applies hereafter to any graph containing error bars).
(F) qPCR for the indicated microRNAs of a time course experiment with SKOM-transduced MEFs; values are referred to MEFs.
Related to Figure S1.
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Cell Stem Cell
A MET Is Needed for Somatic Cell Reprogrammingwe observed that mouse embryonic fibroblasts (MEFs) undergo
epithelial-like morphological changes around day 5. This promp-
ted us to characterize at the molecular level the early events that
accompany the generation of iPSCs from mouse fibroblasts,
aiming to demonstrate the existence of a MET (Figure S1A avail-
able online). MEFs containing a transgenic Oct4 promoter that
expresses GFP (green fluorescent protein) (Silva et al., 2008)
were transduced with combined retroviruses producing SKOM
(Sox2, Klf4, Oct4, and c-Myc) or SKO (samewithout c-Myc) tran-
scription factors. We took phase-contrast photographs at days
5 and 8 postinfection (Figure 1B) and performed immunofluores-
cence microscopy for E-cadherin, b-catenin, pan-cytokeratin
(cytokeratins are highly expressed in epithelia), and actin (Fig-
ure 1C). For comparisons, immunofluorescence of uninfected
mammary epithelial cells (MECs) and MEFs, iPSCs, and R1
mouse ESCs is provided in Figure S1B. MEFs undergoing
reprogramming became rounded and aggregated with quicker
kinetics in SKOM than SKO (Figure 1B). They also formed well-
defined epithelial-like intercellular junctions and displayed
increased cytokeratin starting at day 5 postinfection (Figure 1C).
These epithelial-like clusters appeared before the ESC antigen
SSEA-1 could be detected, as shown by the comparison
between SKOM and SKO (Figure 1C). Western blot analysis vali-
dated the increase in E-cadherin and showed a concomitant
reduction of the mesenchymal-like marker fibronectin (Fn) and
the transcriptional repressor Snail (Figure 1D). Real-time RT-
PCR analysis (qPCR) of three independent SKOM time-course
experiments showed increased mRNA for multiple cell-cell
adhesion proteins (E-cadherin, epithelial-cell adhesion molecule
or Ep-CAM, and diverse desmosomal and tight junction constit-
uents) and cytokeratins, and reduced mRNA for mesenchymal
markers (Fn and N-cadherin), a panel of transcriptional repres-
sors including Snail and Slug, and cell-matrix adhesion genes
(Figure 1E; Figure S1C). SKOM factors also induced rapid down-
regulation of the microRNAs miR-155 and miR-10b, which have
been associated with EMT (Kong et al., 2008; Ma et al., 2007),
and upregulation (albeit more delayed) of miR-205 and -429
(Figure 1F; Gregory et al., 2008; Park et al., 2008), which have
the opposite role. These microRNAs were studied on the basis
of high levels of expression in MECs, iPSCs, and mouse ESCs,
compared to MEFs (Figure S1D). These comprehensive pheno-
typic changes in MEFs undergoing reprogramming had func-
tional repercussions as well, as demonstrated by incomplete
gap closure after wound healing and reduced invasion of Matri-
gel-coated transwell filters (Figures S1E and S1F). Comparable
changes in cell morphology and in the expression of selected
EMT/MET target genes were observed after transduction of
adult mammary fibroblasts (data not shown). Therefore, the
reprogramming of mouse fibroblasts initiates with a bona fide
process of MET that occurs before the acquisition of ESC-like
characteristics.
TGF-b Prevents MET and Blunts the Reprogramming
We next studied whether the observed MET is a consequence
or is required for the formation of iPSCs. TGF-b was recently
described to block nuclear reprogramming (Maherali and
Hochedlinger, 2009) and is a well-known EMT inducer that
acts at least in part through activation of Snail (Peinado et al.,
2003). We added TGF-b1 to MEFs undergoing reprogrammingand observed that it inhibited the upregulation of epithelial
markers and the downregulation of Snail (but not Slug) as
measured by qPCR at day 6 postinfection (Figure 2A); another
TGF-b family constituent, Activin A, did not have any effect.
TGF-b1 and overexpression of Snail also prevented the assem-
bly of intercellular junctions as analyzed at day 6 (Figure 2B; data
not shown) and inhibited the formation of alkaline phosphatase-
positive (AP+) colonies by 40% to 70% measured at days 14
(SKOM) and 25 (SKO) (Figure 2C, upper panel). Besides, the
remaining AP+ colonies were fibroblastic rather than ESC-like
(Figure 2D). TGF-b2 (Maherali and Hochedlinger, 2009) and
TGF-b3 blunted AP+ colony formation as well, but overexpres-
sion of Slug did not have any effect (Figure 2C). The latter indi-
cates specificity and is consistent with Snail and Slug sharing
functions in some settings but not in others (Coˆme et al.,
2006). Although AP staining is a not-stringent-enough criterion
to indicate pluripotency (Brambrink et al., 2008; Silva et al.,
2008), these experiments show that TGF-b and Snail mostly
abort the reprogramming at an early stage. In SKO-infected
MEFs, we also observed that on average 6–12 colonies became
GFP+ (indicative of full reprogramming) by day 25 compared to
few or none in cells treatedwith TGF-b cytokines or overexpress-
ing Snail (Figure 2C, lower panel and Figure 3F). Appearance of
GFP+ colonies in SKOM-infected MEFs required overgrowth of
cells beyond day 20, or secondary splitting, and the frequency
was similar to other studies (0.1% of the original population
[Nakagawa et al., 2008]). However, colonies produced with
SKOM plus TGF-b or Snail remained mostly GFP after multiple
passages (data not shown).We observed reduced cell number in
SKOM- (at day 6) or SKO- (at day 9) infected MEFs treated with
TGF-b cytokines, and it is now known that proliferation is needed
for the acquisition of stochastic epigenetic changes during
reprogramming (Hanna et al., 2009b). But reduced proliferation
in the presence of TGF-b may, if anything, only partially explain
the effect on iPSC colony formation, as for example Snail
increased rather than decreased the cell number (Figure S2).
We also performed DNA microarray analysis of reprogramming
MEFs (at day 10) cultured with TGF-b1 or coexpressing Snail
compared to the control, which showed profound transcriptomic
changes (Table S1). The set of genes differentially modulated
by TGF-b1 and Snail mostly distributed into KEGG (Kyoto
Encyclopedia of Genes and Genomes) pathways related to
cell-cell adhesion and the interaction with the extracellular matrix
(Table S1). Taken together our experiments suggest that MET is
needed for the reprogramming of fibroblasts into iPSCs.
The Yamanaka Factors Suppress EMT by Blocking
TGF-b Signaling
One of the main concerns over iPSC technology is that the
reprogramming efficiency is very low (Silva et al., 2008). We
speculated that high levels of pro-EMT cytokines such as TGF-b
contained in serum or secreted by fibroblasts might impair the
reprogramming by counteracting MET. To assess this, we quan-
tified TGF-b cytokines in our iPSC culture system by using ELISA
and found that two different batches of ESC-defined fetal bovine
serum (FBS) contained significant amounts of TGF-b1 and 2
(Figure 3A) but no TGF-b3 (data not shown). We also noticed
that the starting MEFs and the feeder cells produced abundant
TGF-b1, very low TGF-b2 (Figure 3A), and no TGF-b3 (data notCell Stem Cell 7, 51–63, July 2, 2010 ª2010 Elsevier Inc. 53
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Figure 2. Preventing MET Impairs iPSC Generation
(A) qPCR analysis for the indicated genes of SKOM-infected MEFs (day 6) treated with TGF-b1 or Activin A.
(B) Immunofluorescence (double for E-cadherin and b-catenin, and single for actin) of SKOM-infected MEFs control or treated with TGF-b1; R1 ESCs are also
included as positive control.
(C) Top: quantification via ImagePro 5.0 of AP+ colonies in SKOM- (at day 14) or SKO- (at day 25) infectedMEFs. Mean values for n experiments (n = 9 for SKOM+
TGF-b1; n = 9 for SKOM+Snail; n = 6 for SKO + TGF-b1; n = 4 for SKO +Snail) is provided. Asterisks indicate statistical significance: * < 0.05, ** < 0.01, *** < 0.001;
this also applies hereafter. Bottom: quantification of GFP+ colonies in SKO-infected MEFs treated with TGF-b cytokines or overexpressing Snail.
(D) Phase-contrast photographs of cell morphology and AP staining, and Oct4-GFP immunofluorescence of an SKO experiment with or without TGF-b1 or coex-
pressing Snail; mouse ESCs obtained from OG2 mice were used as a control.
Related to Figure S2 and Table S1.
Cell Stem Cell
A MET Is Needed for Somatic Cell Reprogrammingshown). Interestingly, the reprogramming factors progressively
reduced the secretion of TGF-b1 in the conditioned medium of
SKOM-transduced MEFs, and TGF-b2 increased but levels
were extremely low (Figure 3B). Supporting the ELISA data,
TGF-b1 mRNA (and TGF-b3) diminished in SKOM since early
time points postinfection, while TGF-b2 mRNA was increased
(Figure 3C). TGF-b cytokines bind to TGF-b receptor 2 (TGF-
bR2), which then recruits TGF-bR1 and this triggers autophos-
phorylation (Shi and Massague´, 2003) and a signaling cascade
that ultimately activates Snail; TGF-b receptor 3 (TGF-bR3) acts
as a coreceptor. TGF-bR2 and TGF-bR3 mRNAs were quickly
reduced by the exogenous factors but TGF-bR1 remained rela-
tively unchanged (Figure 3C). TGF-b1, TGF-b3, TGF-bR2, and
TGF-bR3 were very low in R1 ESCs and iPSCs compared to
MEFs, possibly explainingwhy prolonged culture in the presence
of serum or added TGF-b1 cannot induce their differentiation
(Figures S3A–S3C).
Next, we analyzed the contribution of each reprogramming
factor to the above-mentioned transcriptional alterations of54 Cell Stem Cell 7, 51–63, July 2, 2010 ª2010 Elsevier Inc.TGF-b signaling constituents and EMT/MET-related genes, for
which we expressed the four Yamanaka factors individually
and compared their effect with the SKOM and SKO cocktails.
Sox2 and Oct4 suppressed TGF-bR3, Oct4 and Klf4 suppressed
TGF-b3, and c-Myc suppressed TGF-b1 and TGF-bR2 (Fig-
ure 3D), TGF-b2 mRNA was modestly upregulated by Sox2
and Klf4, and none of the factors could independently downre-
gulate TGF-bR1 (data not shown). These data suggest that
SKO factors are less effective in producing iPSCs than SKOM
because without c-Myc the TGF-b pathway is not efficiently
shut down. Supporting this, coexpression of TGF-b receptors
1-3 in SKOM-infected MEFs reduced the number of AP+ colo-
nies as efficiently as a constitutively active form of TGF-bR1
(T204D) (Figure 3E) and picked colonies did not turn GFP+ after
multiple passages compared to the control (data not shown).
This is consistent with whole-genome ChIP-on-Chip analysis
in the study by Sridharan et al. (2009) that shows a pattern of
histone modifications for the TGF-bR2 promoter indicative of
sustained active transcription in pre-iPSCs compared to iPSCs.
Cell Stem Cell
A MET Is Needed for Somatic Cell ReprogrammingWe also detected that incompletely reprogrammed GFP pre-
iPSC clones retain high mRNA levels of TGF-b1 and TGF-bR2,
high levels of Snail and low of E-cadherin, compared to iPSCs
(Figure S3D). On the other hand, use of exogenous (TGF-b
receptor inhibitors or Alk5i) or endogenous (Smad7) (Nakao
et al., 1997) inhibitors of TGF-b signaling improved reprogram-
ming efficiency (based on the number of GFP+ colonies) with
SKO factors to 2% of the original population (Figure 3F). The
effect of Alk5i was less remarkable in SKOM (data not shown),
in agreement with the role of c-Myc in suppressing TGF-b
signaling. Alk5i or Smad7 only moderately increased cell number
at day 9 (Figure S3E), which points to a direct effect on the
reprogramming rather than an indirect effect caused by
stochastic events during cell proliferation. As described in recent
reports (Ichida et al., 2009; Maherali and Hochedlinger, 2009),
we could generate chimera-competent iPSCs from MEFs by
using Alk5i and otherwise nonproductive KOM or KO cocktails
(data not shown), and we saw the same coexpressing Smad7
(Figures 3G and 3H). No colonies were produced when Klf4
was excluded from the retroviral cocktail. In summary, the
combined action of Sox2, Oct4, Klf4, and c-Myc in the recipient
fibroblasts downregulates TGF-b1 secretion and signaling to
prevent the self-perpetuation of EMT, and this is important for
the reprogramming.
E-cadherin Is Required for Reprogramming
Overexpressing the exogenous factors individually, we also
observed that Sox2 and Oct4 downregulate Snail mRNA but
not Slug (Figure 4A), thereby providing an additional way
to shut down EMT during reprogramming. Interestingly, Klf4
potently induced E-cadherin mRNA (more than 200-fold on
average) and other epithelial markers as well (Figure 4B). Upre-
gulation of E-cadherin by Klf4 was verified with western blot,
and Sox2, Oct4, and Klf4 reduced Snail with the same assay
(Figure 4C). This latter effect of Klf4 possibly reflects modulation
of Snail protein stability (Zhou et al., 2004). Immunofluorescence
microscopy further confirmed the increase in E-cadherin trig-
gered by Klf4 (Figure 4D), while bona fide Klf4 binding sites in
the E-cadherin promoter were demonstrated with chromatin
immunoprecipitation (ChIP) and semiquantitative RT-PCR (Fig-
ure 4E). Given that E-cadherin is an important regulator of epithe-
lial homeostasis (Cavallaro and Christofori, 2004) and has been
linked to mouse ESC pluripotency (Chou et al., 2008; Soncin
et al., 2009), we next studied whether knocking down E-cadherin
expression would blunt iPS by preventing MET. For this we used
three different sets of retroviruses producing specific shRNA
hairpins (Figure 5A). The reprogramming was performed in the
presence of vitamin C in order to increase the number of GFP+
colonies and hence magnify differences (Esteban et al., 2010).
The formation of AP+ colonies did not change after knocking
down E-cadherin, but the resulting clones were mostly GFP
and fibroblastic (Figures 5B and 5C) and resembled those
produced with TGF-b1 or Snail (see Figure 2). The few remaining
GFP+ colonies (hereafter named shECAD colonies) displayed
amore loose 2Dmorphology than the control, and three colonies
of each group were picked and expanded for further character-
ization (Figures 5D and 5E). shECAD colonies were SSEA-1 posi-
tive, expressed similar levels of endogenous Oct4 and Nanog
as the controls (Figures 5E and 5F), and had silenced thetransgenes (data not shown). Moreover, they displayed
increased levels of N-cadherin and reduced expression of the
pluripotent genes Lefty1, Sox2, and Klf4 (Figure 5F). The differ-
entiation markers Cer1, Sox17, and Fgf5, which are expressed
in epiblast stem cells (EpiSCs) and the more recently described
FAB-SCs (Chou et al., 2008), were also increased in shECAD
cells compared to the controls (Figure 5F). FAB-SCs were
derived from mouse blastocysts via bFGF, Activin A, and the
GSK3b inhibitor BIO, and share many characteristics of EpiSCs
but are not the same entity. Notably, their phenotype is at least
in part due to reduced E-cadherin expression. The ability of
shECAD cell lines 4 and 8 to form chimeras was strikingly
reduced compared to the controls (Figure 5G). shECAD 9 cells
expressed higher residual levels of E-cadherin (mRNA and
protein) (Figure 5D; Table S2C) and could still produce chimeras
with high frequency but without germline contribution (Fig-
ure 5G). Differences in E-cadherin expression between shECAD
cell lines are probably reflection of different number of shRNA
retroviral insertions into the genome and/or their specific
location. Nevertheless, DNA microarrays showed significant
changes in gene expression in all three shECAD cell lines relative
to the controls, including reduced expression of germline-related
genes like Dazl (Figure S4 and Tables S2A and S2B; Lin et al.,
2008). Stella (Dppa3), a germline-related gene used to differen-
tiate mouse ESCs from EpiSCs (Bao et al., 2009), was not
changed (Figure 5F). Differentially expressed genes between
shECAD cell lines and the controls also displayed an enriched
distribution in pathways related to focal adhesions, actin cyto-
skeleton, the extracellular matrix, and the TGF-b pathway
(Table S2C). The latter suggests that shECAD cell lines may
retain the ability to respond to pro-EMT signals triggered by
TGF-b in the culture medium. In summary, Klf4 induces an
epithelial program during the reprogramming of mouse fibro-
blasts, and in the absence of adequate levels of E-cadherin,
a stable ground condition of ‘‘near pluripotency’’ is established
that differs from EpiSCs and is more similar to FAB-SC cells.
Inducing MET Enhances Reprogramming
Next, we hypothesized that using epithelial cells as a starting
population would improve iPSC generation by circumventing
the need to switch off the EMT state characteristic of fibroblasts.
Indeed, it has been reported that human epithelial cells such
as keratinocytes or hair follicle cells reprogram with higher
efficiency than fibroblasts (Aasen et al., 2008), for which the
authors used a low-serum protocol in order to prevent cell differ-
entiation. We used epithelial cells from the mammary gland
(MECs), a widely used model for studying EMT (Mani et al.,
2008). MECs had to be cultured in low serum to prevent
EMT (Figure 6A; Eirew et al., 2008), and this culture condition
produced significantly more GFP+ colonies than using fibro-
blasts and a full serum protocol (Figure 6B). Addition of Alk5i to
MECs cultured with serum also prevented EMT and generated
GFP+ iPSC colonies with high efficiency (Figures 6A and 6B).
Interestingly, we observed that MECs express high endogenous
levels of the complementary factor Klf4, which quickly dimin-
ished in the presence of serum unless the cells were treated
with Alk5i (Figure 6C). Consistent with a major role of Klf4 during
the reprogramming being the induction of MET, and because
epithelial cells don’t need such transition, we could successfullyCell Stem Cell 7, 51–63, July 2, 2010 ª2010 Elsevier Inc. 55
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Figure 3. Sox2, Oct4, and c-Myc Suppress TGF-b Signaling
(A) Measurement via ELISA of TGF-b1 and TGF-b2 in mouse ESC-tested FBS (lot 1 number 709778, lot 2 number 737443) and conditioned medium (CM)
from uninfected MEFs and feeder layers. For collecting supernatants, cells (1.8 3 105 MEFs and 2 3 105 feeders) were split on 6-well dishes and cultured
with Optimem + 0.5% FBS for 48 hr.
(B) ELISA for TGF-b1 and TGF-b2 in the conditioned supernatant of control and SKOM-infectedMEFs. Valueswere normalized to the amount of protein contained
in lysates from the same wells.
(C) qPCR of three independent SKOM time-course experiments for the indicated genes.
(D) qPCR for the indicated genes (three independent experiments) at day 6 after transducing MEFs with the exogenous factors individually. Infections with SKO
and SKOM were performed in parallel as controls.
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Figure 4. Klf4 Activates an Epithelial Gene Expression Program
(A and B) qPCR for the indicated genes at day 6 after transducing MEFs with the exogenous factors individually; infections with SKO and SKOM were used as
controls.
(C) Western blot for E-cadherin and Snail in MEFs overexpressing the exogenous factors individually.
(D) Immunofluorescence microscopy of MEFs overexpressing Klf4; empty vector and a retroviral plasmid encoding E-cadherin are the controls.
(E) Schematic representation of the E-cadherin promoter andChIPwith anti-Klf4. Positions for the respective putative binding sites (identified withMatt Inspector)
are: for region 1, 3615 and 3499; region 2, 2915 and 2853; region 3, 473 and 351; and region 4, +477 and +515.
Cell Stem Cell
A MET Is Needed for Somatic Cell Reprogrammingreprogram MECs cultured with Alk5i with only Sox2 and Oct4
(SO). Semiquantitative RT-PCR of genomic DNA was used to
detect specific transgene integration and exclude the possibility
of plasmid contamination (Figure 6D). These iPSC clones, and
also those produced as in Figure 6B, exhibited ESC characteris-
tics and were pluripotent (Figures 6E–6J; Figure S5). Therefore,
the maintenance of an epithelial phenotype facilitates reprog-
ramming and Klf4 can be omitted from the reprogramming cock-
tail when epithelial cells are used as donor cells.(E) Effect on the number of AP+ colonies of coexpressing the TGF-b receptors (eith
as a positive control.
(F) Quantification of AP+ and GFP+ colonies in SKO-infected MEFs treated with
(G) qPCR for measuring the expression of ESC genes (left) and the exogenous tran
KO colonies produced with Alk5i were also included. For the transgenes, RNA fro
tive and negative controls, respectively.
(H) Photographs of a chimeric mouse produced with iPSC clones derived from M
Related to Figure S3.DISCUSSION
We have identified a key cellular process, MET, as an early requi-
site event during the reprogramming of mouse fibroblasts into
iPSCs by exogenous factors. Our work also shows that somatic
cell reprogramming is not merely a nuclear event but rather that
it is determined by the fine crosstalk between nuclear engines
and the extracellular milieu. The machinery triggered by the
exogenous factors initiates the MET program to powerer individually or in combination) together with SKOM factors; T204Dwas used
Alk5i or coexpressing Smad7; control TGF-b1 treatment is included.
sgenes (right) in KO + Smad7 and KOM+ Smad7 iPSCs generated fromMEFs;
m SKOM-transduced cells extracted at day 6 and R1 ESCs were used as posi-
EFs transduced with KO + Smad7.
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Figure 5. E-cadherin Is Needed for the Reprogramming of MEFs
(A) qPCR for E-cadherin in MEFs transduced with SKOM and the indicated shRNA vectors; Luc-shRNA indicates control shRNA.
(B) Effect of knocking down E-cadherin on the appearance of AP+ and GFP+ colonies in SKOM- and SKO-infected MEFs.
(C) Representative GFP+ colonies produced with control shRNA and non-ESC-like GFP colonies representative of most colonies produced with shRNA vectors
for E-cadherin.
(D) Western blot for E-cadherin in three expanded GFP+ shRNA control clones (hereafter labeled as ctrl) or E-cadherin shRNA.
(E) Immunofluorescence microscopy for the indicated markers of a control clone and an shECAD clone.
(F) qPCR for the indicated genes in two shECAD and two control cell lines.
(G) Table summarizing the injection of control iPSCs and shECAD cell lines into heterologous blastocysts for chimeric mice generation.
Related to Figure S4 and Table S2.
Cell Stem Cell
A MET Is Needed for Somatic Cell Reprogrammingfibroblasts through an epigenetic barrier established throughout
development, very probably during EMT processes involved in
early differentiation decisions. EMT andMET are subject to regu-
lation not only at the transcriptional level but also by the extracel-
lular environment (Peinado et al., 2003). Hence, pro-EMT cyto-
kines in the culture medium can create an EMT-compatible
situation that sustains the fibroblast-like identity, prevents
MET, and results in abortive reprogramming despite maintained
expression of the exogenous factors inside the nuclei of infected
cells. To bypass this, the exogenous factors must suppress an
intrinsic barrier represented by fibroblast-enriched transcription
factors (e.g., Snail) that preserve the mesenchymal phenotype,
and another one extrinsic typified by TGF-b1 (and possibly other
cytokines as well) contained in the culture medium. While the
nuclear engines try to eliminate the first hurdle (e.g., suppressing
Snail and inducing E-cadherin), the extracellular milieu can still58 Cell Stem Cell 7, 51–63, July 2, 2010 ª2010 Elsevier Inc.derail the process by providing positive feedback on Snail,
unless a TGF-b inhibitor is added. In this regard, it was reported
recently that Alk5i can help maintain rat iPSCs dedifferentiated
(Li et al., 2009) and improves mouse (Ichida et al., 2009; Maherali
and Hochedlinger, 2009) and human (Lin et al., 2009) iPSC
generation. These articles suggested that blockade of EMT is
important for reprogramming, but no experimental proof or
mechanistic insight (apart from the involvement of Nanog [Ichida
et al., 2009]) was provided. Here we have shown that Sox2/Oct4
and c-Myc suppress Snail and TGF-b1/TGF-bR2, respectively,
and Klf4 upregulates E-cadherin and other epithelial genes
(Figure 7). In this context it is straightforwardly understood that
Alk5i or Smad7 can substitute Sox2 and c-Myc when iPSCs
are generated from fibroblasts, and that Klf4 is rescindable
from the reprogramming cocktail in epithelial cells. By dissecting
this network, we demonstrate that rational approaches based on
Cell Stem Cell
A MET Is Needed for Somatic Cell Reprogrammingunderstanding iPSC in a cell-specific and tissue culture-specific
context may lead to better practice. Additional exploration of
these pathways may as well provide novel ways to improve the
quality of iPSCs and/or the generation efficiency and perhaps
facilitate the use of nonintegrating approaches.
Regarding how TGF-b and Snail ultimately exerts their effects,
this may involve several targets but a critical step is downregula-
tion of E-cadherin. Snail is needed for EMT during gastrulation
(Carver et al., 2001; Murray and Gridley, 2006) and its overex-
pression induces ESC differentiation (Ivanova et al., 2006). On
the other hand, E-cadherin knockout mice do not proceed
beyond the epiblast stage (Larue et al., 1994) and a number of
reports have linked this molecule to pluripotency (Chou et al.,
2008; Soncin et al., 2009). For example, FAB-SCs (Chou et al.,
2008) and E-cadherin/ mouse ESCs (Soncin et al., 2009) are
trapped in a semipluripotent state that shares similarities with
EpiSCs (Bao et al., 2009) including the failure to form chimeric
mice. It is therefore not surprising that mouse ESC differentiation
and somatic cell reprogramming converge in the same cross-
road represented by E-cadherin. As for how E-cadherin knock-
down blocks reprogramming, this does not seem to involve
b-catenin signaling (Clevers, 2006) because this molecule is
well confined to intercellular junctions in shECAD iPSC clones
(see Figure 5E) possibly through interaction with N-cadherin.
Moreover, we did not see any effect when b-catenin was coex-
pressed with SKO or SKOM in MEFs (data not shown), and in
the original description by Yamanaka (Takahashi and Yamanaka,
2006), b-catenin moderately enhanced iPSC generation.
Instead, E-cadherin may regulate pluripotency by ensuring that
fully compacted cells have access to putative critical autocrine
signals or by promoting cell-cell exchange of signals perhaps
through gap junctions (Houghton, 2005). Because E-cadherin
has also been linked to pluripotency in human ESCs (Li et al.,
2010), it is likely that its knockdown will influence as well human
somatic cell reprogramming. But human ESCs rely on TGF-
b signaling to maintain their characteristics (James et al., 2005)
and it remains to be seen whether the epigenetic remodeling of
human iPSCs generated with or without Alk5i are equivalent.
Importantly, E-cadherin is not the only mechanism by which
Klf4 induces reprogramming, as shown by the fact that substitu-
tion of this transcription factor by E-cadherin could not produce
iPSC clones in MEFs (data not shown). Coexpression of E-cad-
herin did not increase either the reprogramming efficiency of
SKOM- or SKO-infected MEFs (data not shown), though this
could be due to quick E-cadherin upregulation after transduction
with the exogenous factors. It is possible that other Klf4-regu-
lated adhesion molecules play as well a role during reprogram-
ming, but redundancy may exist and for example knockout
mice for tight junction molecules like Occludin or the Claudins
show a milder phenotype (Furuse, 2009) compared to E-cad-
herin. Likewise, shRNA for Snail did not increase the efficiency
of reprogramming in SKOM- or SKO-infected MEFs (data not
shown), which could imply that other transcriptional repressors
(see Figure 1C) participate too or that rapid Snail downregulation
during reprogramming does not allow further improvement. Our
DNA arrays also suggest that the effects of TGF-b1 and Snail
involve the actin cytoskeleton and extracellular matrix, but this
could be a consequence and not the cause (see Table S1).
Further study of how E-cadherin knockdown blocks iPSCs anda more detailed comparison between shECAD cell line EpiSCs
and FAB-SCs will be relevant to understand the reprogramming
process and the metastable character of ESCs (Guo et al., 2009;
Hanna et al., 2009a).
Interestingly, EMT has been shown to induce stem cell proper-
ties in mammary epithelial cells (Mani et al., 2008), which
contrasts with our results presented here but probably reflects
that pluripotency and stemness are not the same. In any case,
knowledge diverted from EMT in this or other contexts may allow
better understanding of reprogramming, and the reverse situa-
tion can be envisaged too. For example, TGF-bR2 is reduced
in liver tumors overexpressing c-Myc (Amicone et al., 2002;
Factor et al., 1997), and it is well known that epithelial cells
express high levels of Klf4 (De Craene et al., 2005). Yet, a direct
link between TGF-bR2 and c-Myc or a dominant role for Klf4 in
controlling epithelial characteristics had not yet been described.
Interestingly, Klf4 is repressed by Snail during EMT of MECs (De
Craene et al., 2005) and it is tempting to speculate that TGF-b/
Snail may block nuclear reprogramming by directly preventing
the activation of endogenous Klf4 and perhaps other pluripo-
tency regulators as well.EXPERIMENTAL PROCEDURES
Cell Culture
MEFs andMECs from OG2mice (Silva et al., 2008) were isolated as described
(Mani et al., 2008). ESCs from OG2mice were also isolated as described (Ying
et al., 2008) and where indicated we used R1 mouse ESCs (purchased from
ATCC). MEFs and MECs were transduced at passage 2 or 3 with pMX-based
retroviruses in 6-well culture dishes as in previous reports (Esteban et al.,
2010). For SKOM, 2,000 cells were split on feeders at day 6, for SO 20,000
at day 9, and for other factor combinations 5,000 cells at day 9. MEF medium
(high-glucose DMEM [HyClone], nonessential amino acids [GIBCO], penicillin/
streptomycin, L-glutamine, and 10% FBS [HyClone]) or MECmedium (DMEM/
F12 [Invitrogen] supplemented with 2% FBS [GIBCO; 15% in the full serum
condition], 10 mmol/L HEPES, 10 ng/mL epidermal growth factor [Invitrogen],
10 mg/mL insulin [Invitrogen], 5% bovine serum albumin, and penicillin/strep-
tomycin) was changed at day 2 postinfection to standard mouse ESC culture
medium (high-glucose DMEM, nonessential amino acids, penicillin/strepto-
mycin, L-glutamine, leukemia inhibitory factor [Millipore], beta-mercaptoetha-
nol, sodium pyruvate, and 15% FBS [GIBCO]). TGF-b1-3 and Activin A were
from R&D Systems and used at 2 ng/ml and 10 ng/ml, respectively. A-83-01
(0.5 mM) was purchased from Tocris and added from day 3 to the end of
the experiment except for MECs (added since moment of derivation). Vitamin
C was purchased from Sigma and used at 50 mg/ml from day 3 until the end
of the indicated experiments. Established iPSCs used throughout as controls
were produced from MEFs via SKO factors and proved to be chimera
competent.
Plasmids and ChIP
pMX-Snail and pMX-E-cadherin were subcloned from plasmids provided by
Dr. Antonio Garcia de Herreros and Dr. Masatoshi Takeichi, respectively;
pMX-Slug, TGF-bR1-3, T204D (Wieser et al., 1995), and Smad7were prepared
by ourselves with cDNA from MEFs as a template and site-directed muta-
genesis (T204D). All cDNAs correspond to mouse and were verified by
sequencing. ELISA kits for TGF-b1-3 were from R&D Systems. pRetroSuper
vectors containing shRNA sequences for E-cadherin or the control firefly
luciferase gene were also made by us; after infection, cells were selected
in puromycin for 3 days. The target sequences for Ecad-shRNA3 were GGAG
ATGCAGAATAATTAT (Chou et al., 2008), Ecad-shRNA5 GCTGGAATCTTTG
TCCATGTA, and Ecad-shRNA11 GCAGGAAGAGAACATTCTA. After infection
with shRNA vectors,MEFswere treatedwith puromycin fromday 3 to 5, split on
feeder at day 6, and thenmaintainedwithout theantibiotic.ChIPwasperformed
with a Klfh-specific kit purchased from R&D Systems.Cell Stem Cell 7, 51–63, July 2, 2010 ª2010 Elsevier Inc. 59
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Figure 6. Maintenance of Epithelial Characteristics Is Needed for the Efficient Reprogramming of MECs
(A) Phase-contrast photographs and immunofluorescence microscopy of MECs derived in the indicated culture conditions.
(B) Time-course quantification of GFP+ colonies in MECs derived in the indicated conditions and transduced with SKOM factors.
(C) qPCR of endogenous Klf4 in MECs cultured for 5 days as indicated, R1 ESCs were used as positive control.
(D) Phase-contrast photographs and immunofluorescence microscopy for Oct4-GFP or selected ESC markers in SO (four clones were produced out of 43 104
transduced cells) iPSCs produced from MECs treated with Alk5i (A-83-01).
(E) Top: qPCR for measuring the expression of ESC genes in SO iPSCs from MECs, R1 ESCs were used as a positive control. Bottom: qPCR for the exogenous
transgenes in the same SO iPSCs; RNA from SKOM-transduced cells extracted at day 6 and uninfected MECs were used as positive and negative controls,
respectively.
(F) Semiquantitative RT-PCR (MEFs infected at day 6 were the positive control) to detect exogenous transgene integration.
(G) DNA methylation profile of the Oct4 and Nanog proximal promoters in uninfected MECs, R1 ESCs, and SO iPSCs derived from MECs.
Cell Stem Cell
A MET Is Needed for Somatic Cell Reprogramming
60 Cell Stem Cell 7, 51–63, July 2, 2010 ª2010 Elsevier Inc.
Oct4 Sox2
Myc
Tgfb3
TgfbR3
TgfbR2 Tgfb1
Snail
EMT
Klf4
E-cadherin
 
Snail
MET
Oct4 Sox2Klf4
Endo-
Klf4
A B
Figure 7. Molecular Network for the
Suppression of EMT and Activation of MET
by the Exogenous Factors
(A) Schematic representation of how the exoge-
nous factors suppress TGF-b signaling to prevent
the self-perpetuation of EMT in the reprogramming
fibroblasts.
(B) Schematic representation of the suppression of
Snail by Oct4 and Sox2 and the activation of an
epithelial program by Klf4 during the reprogram-
ming of fibroblasts.
Cell Stem Cell
A MET Is Needed for Somatic Cell ReprogrammingCell Line Characterization
Antibodies were purchased from Cell Signal (E-cadherin), BD Bioscience
(b-catenin), Abcam (pan-cytokeratin and Snail), Sigma (Fn and actin), Invitro-
gen (SSEA-1), and R&D systems (Nanog); Sox2/Oct4 and Rex1 were self
made. Rodamine-phalloidin was used to stain actin and we purchased
it from Invitrogen. Cells were fixed with ice-cold methanol for 10 min at
20 degrees, except for rhodamine-phalloidin staining that required parafor-
maldehyde, and washed with PBS. A Leica TCS SP2 Spectral confocal
microscope was used for all immunoflorescence studies. qPCR was per-
formed with SYBR green (Takara), and samples were analyzed in triplicate
and normalized on the basis of b-actin values. Sequences for these and
other primers are available upon request. MicroRNAs were measured by
qPCR with SYBR green as reported by others (Chen et al., 2005). Western
blotting detection was performed with ECL+ (Amersham). Transwell cham-
bers were purchased from Millipore and stained according to the instructions
by the manufacturer. Karyotyping, bisulfate sequencing, semiquantitative
RT-PCR for detecting transgene integration, AP staining, teratomas, and
injection of iPSCs into chimeric mice were performed like in our previous
reports (Esteban et al., 2010). DNA microarrays were performed with Gene-
Chip Mouse Genome 430 2.0 Array (for Figure S3B) and MoGene 1.0 ST chip
(the others) from Affymetrix. A Zeiss SteREO Lumar V12 fluorescence micro-
scope was used to observe GFP+ germ cells in the genital ridge of embryos
extracted at 13 and a half days. Statistical significance was evaluated where
convenient with Student’s t test. All experiments involving animals were
approved by the Guangzhou Institutes of Biomedicine and Health review
board.ACCESSION NUMBERS
GEO database accession numbers are GSE15267, GSE21062, GSE21064,
and GSE21067.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and two tables and can be
found with this article online at doi:10.1016/j.stem.2010.04.014.(H) Karyotype for the same SO iPSCs.
(I and J) Hematoxylin/eosin-stained sections of teratomas composed of tissues derived from the three germ la
from MECs.
Related to Figure S6.
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